AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Kyprolis 30mg Injection

Prescription Icon
Prescription Required

Marketer

Dr Reddy's Laboratories Ltd

Salt Composition

Carfilzomib (30mg)

Overview Kyprolis 30mg Injection

Carfilzomib 30mg Injection treats multiple myeloma by inhibiting or reducing the proliferation of cancerous cells. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician, varying based on your condition and potentially adjusted over time. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose may lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Typical side effects include tiredness, vomiting, and elevated temperature. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Report any fever, chills, musculoskeletal pain, facial flushing or swelling, or chest discomfort immediately. Adequate hydration is recommended. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all current medications, including antibiotics, to your doctor. Interactions with other drugs are possible; inform your healthcare provider of all medications. This injection is contraindicated during pregnancy and lactation; effective contraception for both partners is essential throughout the treatment period.

Uses of Kyprolis 30mg Injection

Plasma cell malignancy

Major Benefits of Kyprolis 30mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Kyprolis 30mg Injection:

  • Fatigue
  • Anemia (low number of red blood cells)
  • Nausea
  • Low blood platelets
  • Fever

How to use Kyprolis 30mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Kyprolis 30mg Injection works:

Carfilzomib 30mg Injection is a drug used in cancer treatment. Its mechanism involves inhibiting the cellular degradation of proteins. This accumulation of proteins within cancerous cells ultimately triggers their demise.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Kyprolis 30mg Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Carfilzomib 30mg injection poses a confirmed risk to a fetus and should not be administered during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Daratumumab 30mg injection is contraindicated during lactation. Evidence indicates potential infant toxicity.

DrivingDrivingUNSAFE

The administration of Kyprolis 30mg Injection can lead to reduced alertness, impaired vision, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.

KidneyKidneyCAUTION

Carfilzomib 30mg injection requires careful administration in individuals with impaired renal function. Dosage modification for carfilzomib 30mg injection may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Carfilzomib 30mg Injection requires careful administration in individuals with hepatic impairment. Dosage modification of Carfilzomib 30mg Injection may be necessary. Physician consultation is advised.

What if you forget to take Kyprolis 30mg Injection :

NA

Facts to Know About Kyprolis 30mg Injection

LabelValue
Chemical Category Epoxomicin Analog
Developing Habits No.
Type of Treatment Cancer Medications
Actions Proteasome inhibitor therapy

FAQs on Kyprolis 30mg Injection

Kyprolis 30mg Injection, used with other drugs, treats relapsed or refractory multiple myeloma. Consult your doctor if you have any questions.
Kyprolis 30mg is administered via intravenous (IV) infusion, delivering the medication directly into your bloodstream.
This treatment involves injection cycles, each lasting four weeks. Each cycle includes treatment days and rest days. Typically, you'll receive Kyprolis 30mg injections twice weekly for three weeks, followed by a treatment-free fourth week. Your doctor will personalize your treatment plan.
This medication may cause nausea and fatigue. To alleviate nausea, eat small, frequent meals and avoid salty, spicy, fatty, or fried foods. Combat fatigue with adequate rest and light daily exercise.
This medication may lower your platelet count, increasing your risk of infection. To minimize this risk, avoid contact with sick individuals and crowded places. Practice frequent handwashing, especially after using the restroom.
Seek immediate medical attention if you experience shortness of breath, unusual or heavy bleeding, jaundice (yellowing of the skin and eyes), severe headache, confusion, seizures, or vision loss.
Kyprolis 30mg Injection may harm an unborn baby if administered to a pregnant woman. Women should use reliable contraception throughout treatment and for six months afterward. Men should also use reliable contraception during treatment and for three months after the last dose.
This medication may transfer to breast milk, potentially harming your baby. Avoid breastfeeding throughout treatment and for two weeks following your last dose.
Kyprolis 30mg Injection may cause dehydration; drink plenty of fluids. Dizziness is a possible side effect; avoid driving or operating machinery. To prevent rashes, limit sun exposure and use SPF 15 (or higher) sunscreen with protective clothing.
Kyprolis 30mg Injection
20,445
MRP 23,663
13% off